K

Kotra Industries Bhd
KLSE:KOTRA

Watchlist Manager
Kotra Industries Bhd
KLSE:KOTRA
Watchlist
Price: 4.05 MYR -0.25%
Market Cap: 39.2m MYR

Kotra Industries Bhd
Investor Relations

Kotra Industries Bhd.is an investment holding company, which engages in the manufacturing and trading of pharmaceutical and healthcare products. The company is headquartered in Malacca, Melaka and currently employs 660 full-time employees. The company went IPO on 2000-10-30. The Company, through its subsidiary, Kotra Pharma (M) Sdn. Bhd, is engaged in pharmaceutical and healthcare products manufacturing and trading business. Its segments include Malaysia, Asia and Africa. Its products include Appeton Multivitamin Pastilles, which is a healthy chewable pastille (non-sugar coated) for children; Axcel Glimepiride Medication, which is used to treat diabetes mellitus type 2; Axcel Bromhexine (Children) Syrup, which is a mucolytic medicine used in the treatment of respiratory chest congestion; Arite Beclometasone 50mcg (Metered Dose Inhaler Product), which is used in long-term management of asthma; Vaxcel Granisetron Injection, which is an antiemetic to treat nausea and vomiting following chemotherapy and radiotherapy, and Axcel Atenolol, which is used to treat high blood pressure and heart-associated chest pain.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Teck Onn Piong
MD & Director
No Bio Available
Ms. Swee Chang Chin
Chief Information Officer & Executive Director
No Bio Available
Mr. Chong Liang Chua
Chief Financial Officer
No Bio Available
Mr. Ming Loong Cheah
Chief Operating Officer
No Bio Available
Ley-Theng Tan
Joint Secretary
No Bio Available

Contacts

Address
MELAKA
MALACCA
No. 1, 2 & 3, Jalan TTC 12, Cheng Industrial Estate
Contacts
+6063362222
www.kotrapharma.com
sparklesyt

See Also

Summary
KOTRA intrinsic value, competitors valuation, and company profile.
DCF Valuation
KOTRA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
KOTRA stock valuation using valuation multiples.
Wall Street Estimates
KOTRA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
KOTRA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 244,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.